Q2 2020 BioArctic AB Earnings Call Transcript
Hello, and welcome to the BioArctic Q2 Report 2020. (Operator Instructions) Just to remind you, this conference call is being recorded.
Today, I'm pleased to present CEO, Gunilla Osswald; and CFO, Jan Mattsson. Please begin your meeting.
()-
Thank you so much, and welcome to BioArctic's Interim Report for the First Half of 2020. I'm Gunilla Osswald, and I'm the CEO of BioArctic, and I will share the presentation here today with our CFO, Jan Mattsson.
The first half of 2020 has been very good for BioArctic in spite of the tough situation around us with the COVID-19 pandemic. With a strong cash position and an expanded project portfolio, we are progressing the business in a good way, and that's thanks our great personnel and our great partners.
Next slide, please. BioArctic is listed on Nasdaq Stockholm Mid Cap, and this is our disclaimer.
Next slide, please. BioArctic is a unique Swedish biopharma company with the aim of improving lives for patients with
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |